Bond Labs Up in 1Q

OMAHA, Neb. Bond Laboratories Inc. (OTCBB: BNLB) released its financial results for the quarter ending March 31, 2010 (1Q10). Revenue for the quarter hit $2.4 million, a 13.7 percent increase over the comparable period in 2009. According to the company, the primary growth driver was the companys NDS division, which sells dietary supplements and nutritional products; revenue in NDS was up 22.2 percent year-over-year for the quarter and up 36.2 percent for the month ended March 31, 2010.

We are delighted with our results in Q1, said John Wilson, CEO. Our NDS division continues to exceed expectations, a trend we believe will continue throughout the remainder of 2010. We are also extremely pleased with the early success of the Resurrection product launch and are excited about the prospects and potential for this category creating product as we continue to expand its distribution footprint and mindshare with consumers.